ClinicalTrials.Veeva

Menu

Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion

U

Ulsan Medical Center

Status

Enrolling

Conditions

Drug-coated Balloon

Treatments

Device: drug-coated balloon

Study type

Observational

Funder types

Other

Identifiers

NCT04619277
USH-20-004 (Registry Identifier)

Details and patient eligibility

About

This study is the international multicenter registry for drug-coated balloon treatment for de novo coronary lesion.

Full description

There is lots of evidence that DCBs result in lower rates of restenosis, thrombosis, and better long-term outcomes when used for PCI of in-stent restenosis (ISR) compared to plain old balloon angioplasty (POBA) or additional stenting with drug-eluting stent (DES). DCB-only approach studies for de novo coronary lesion cases are scarce, but a recent registry data suggested it was a feasible and well-tolerated treatment method if the pre-dilation result is good. Therefore, the aim of this study was to evaluate the safety and efficacy in terms of angiographic and clinical outcomes of a DCB-only approach for de novo coronary lesions.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • de novo coronary artery disease

Exclusion criteria

  • unstable hemodynamics at presentation
  • life expectancy <1 year

Trial design

10,000 participants in 7 patient groups

Ulsan Medical Center
Description:
Division of Cardiology, Department of Internal Medicine, Ulsan Medical Center, Ulsan, South Korea
Treatment:
Device: drug-coated balloon
Queen Elizabeth Hospital
Description:
Cardiology Department and Clinical Research Center, Queen Elizabeth Hospital II, Kota Kinabalu, Malaysia
Treatment:
Device: drug-coated balloon
Pecking University Shougand Hospital
Description:
Department of Cardiology, Peking University Shougang Hospital, Peking, China
Treatment:
Device: drug-coated balloon
Ulsan University Hospital
Description:
Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea
Treatment:
Device: drug-coated balloon
Kangwon National University School of Medicine
Description:
Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea
Treatment:
Device: drug-coated balloon
Korea University Guro Hospital
Description:
Cardiovascular Center, Department of Cardiology, Korea University Guro Hospital, Seoul, South Korea
Treatment:
Device: drug-coated balloon
Korea University Ansan Hospital
Description:
Department of Cardiology, Korea University Ansan Hospital, Ansan, South Korea
Treatment:
Device: drug-coated balloon

Trial contacts and locations

1

Loading...

Central trial contact

Eun-Seok Shin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems